Open AccessHistorical analysis of leishmaniasis cases in the transamazonian region: from 2009 to 2019
Author(s) -
Alexandre Apolo Silva Coelho,
Evellyn Vitória Sousa de Loureiro,
Andrey Caique Jorge da Silva,
Ana Beatriz Costa da Silva,
Helton Correa Alves,
Dalberto Lucianelli-Junior,
Antônio Vivaldo Pantoja,
Ozélia Sousa Santos,
Renan Rocha Granato,
Ademir Ferreira da Silva-Júnior,
Roberto Manoel do Nascimento,
Ronaldo Zucatelli Mendonça,
Rogério Valois Laurentino,
Fernanda Nogueira Valentin
Publication year - 2021
Publication title -
revista eletrônica acervo saúde
Language(s) - English
Resource type - Journals
ISSN - 2178-2091
DOI - 10.25248/reas.e9163.2021
Subject(s) - coinfection , medicine , concordance , leishmaniasis , cutaneous leishmaniasis , public health , lesion , dermatology , leishmania , human immunodeficiency virus (hiv) , environmental health , surgery , pathology , immunology , parasite hosting , world wide web , computer science
Objective: To determine the total number of notified cases, new cases and recurrence of American Tegumentary Leishmaniasis (ATL), to investigate the association between HIV coinfection and the presence of cutaneous lesion, as well to assess the concordance of two different laboratorial procedures: parasitological and histopathological in this region. Methods: This is a cross-sectional study. The research used data from the Information System for Notifiable Diseases, hence forth designated as SINAN (Sistema de Informação de Agravos de Notificação) that contained 6,183 cases of leishmaniasis in 9 municipalities. Results: As results, 5795 were of new cases and 351 recurrence cases. Among the cases 1,146 patients were tested for HIV, 16 presented coinfection from these 15 developed cutaneous lesion. In the overall studied population 5,690 subjects manifested cutaneous lesion. There was no agreement of the results regarding the quality of the parasitological and histopathological exams, demonstrating that they are poorly replicable (p <0.005). Conclusion: The ATL is endemic in the transamazonian region posing as a major public health problem. All patients with leishmaniasis must be tested for HIV and health professionals must register on the notification form. The tests to diagnose leishmaniasis need to be more specific and sensitive.